Anika Therapeutics: Q4 Earnings Insights

Comments
Loading...

Anika Therapeutics ANIK reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Anika Therapeutics beat estimated earnings by 119.0%, reporting an EPS of $0.05 versus an estimate of $-0.26.

Revenue was up $3.35 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.37 which was followed by a 11.0% increase in the share price the next day.

Here's a look at Anika Therapeutics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.37 -0.27 -0.30 -0.24
EPS Actual 0 0.06 -0.36 -0.21
Revenue Estimate 38.27M 40.56M 37.28M 37.70M
Revenue Actual 41.47M 44.30M 37.92M 39.62M

To track all earnings releases for Anika Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANIK Logo
ANIKAnika Therapeutics Inc
$16.86-1.46%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum14.39
Growth33.64
Quality-
Value72.63
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: